https://pipelinereview.com/vertex-initiates-phase-3-study-of-vx-659-tezacaftor-and-ivacaftor-as-a-triple-combination-regimen-for-people-with-cystic-fibrosis-who-have-two-copies-of-the-f508del-mutation/